Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Treatment (Pilot Study)”

204 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 204 results

Post-approval studies (Phase 4)Ended earlyNCT00936663
What this trial is testing

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

Who this might be right for
Type 2 DiabetesEnd Stage Renal Disease
University of Nebraska 3
Testing effectiveness (Phase 2)Ended earlyNCT00982293
What this trial is testing

The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Who this might be right for
Type 2 Diabetes
pico-tesla Magnetic Therapies, LLC 165
Post-approval studies (Phase 4)Study completedNCT00191178
What this trial is testing

Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 60
Early research (Phase 1)Study completedNCT00425178
What this trial is testing

FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers

Who this might be right for
Chronic WoundsDiabetesVenous Stasis Ulcers
Venturis Therapeutics, Inc. 8
Not applicableStudy completedNCT05514080
What this trial is testing

Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
McGill University 10
Early research (Phase 1)UnknownNCT01142050
What this trial is testing

Stem Cell Therapy for Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Cellonis Biotechnology Co. Ltd. 24
Post-approval studies (Phase 4)Study completedNCT00335465
What this trial is testing

Lantus Effect on Myocardial Glucose Metabolism in T2

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 15
Testing effectiveness (Phase 2)Study completedNCT05351879
What this trial is testing

Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Linkoeping University 6
Testing effectiveness (Phase 2)Study completedNCT03772964
What this trial is testing

Effects of Metformin in a Non-Diabetic Patient Population

Who this might be right for
Inflammatory Response
Brian Zuckerbraun 32
Post-approval studies (Phase 4)UnknownNCT03700645
What this trial is testing

Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease

Who this might be right for
Diabetes MellitusIschemic Heart DiseaseMulti Vessel Coronary Artery Disease
Tel-Aviv Sourasky Medical Center 100
Not applicableLooking for participantsNCT06897982
What this trial is testing

Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center

Who this might be right for
Prediabetic StatePreDiabetesHealth Knowledge, Attitudes, Practice+3 more
Cedars-Sinai Medical Center 20
Not applicableUnknownNCT03787563
What this trial is testing

Herbal Tea in the Treatment of Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Composite Interceptive Med Science 10
Not applicableStudy completedNCT02797392
What this trial is testing

Feasibility of a Preventive Program Against Lifestyle Related Diseases

Who this might be right for
Type-2 DiabetesCardiovascular DiseasesChronic Obstructive Pulmonary Disease (COPD)
University of Southern Denmark 9,400
Early research (Phase 1)WithdrawnNCT00214214
What this trial is testing

A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus

Who this might be right for
New Onset Type 1 Diabetes Mellitus
University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT00727896
What this trial is testing

"Information Technology Methodology for Patient Motivation in Diabetes Management."

Who this might be right for
Type 2 Diabetes
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals 200
Post-approval studies (Phase 4)Study completedNCT00571506
What this trial is testing

Effect of Thiazolidinedione Treatment Vascular Risk Markers

Who this might be right for
Diabetes Mellitus, Type 2Vascular Diseases
University of Arkansas 25
Not applicableStudy completedNCT01297049
What this trial is testing

I-care: Stimulating Self-management in Patients With Type 2-diabetes

Who this might be right for
Diabetes Type 2Obesity
Oslo Metropolitan University 15
Not applicableStudy completedNCT03615755
What this trial is testing

Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine

Who this might be right for
Hyperbaric Oxygen TherapyDiabetic Foot UlcerType II Diabetes Mellitus
Hendry Irawan 30
Not applicableUnknownNCT02705430
What this trial is testing

Effect of EPA-DHA Supplement, Life Style Modification Standard Treatment on Clinical Outcome Lipid Membrane Composition in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Rabin Medical Center 60
Not applicableNot Yet RecruitingNCT07275086
What this trial is testing

Therapeutic Outcomes of Using Complementary Hand-based Treatment in Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
University Hospital, Linkoeping 20
Next Page